Cytosorbents Corp (CTSO) › Net IncomeCytosorbents Corp (CTSO) — Net IncomeAnnual figures by fiscal year, from SEC filings.1998: -$1.87M1999: -$10.75M2000: -$3.07M2001: -$15.39M2002: -$11.87M2003: -$6.01M2004: -$1.10M2005: -$3.67M2006: -$76.72M2007: -$3.35M2008: -$3.02M2009: -$2.74M2010: -$2.91M2011: -$5.48M2012: -$3.66M2013: -$4.68M2014: -$9.32M2015: -$9.48M2016: -$11.76M2017: -$8.46M2018: -$17.21M2019: -$19.27M2020: -$7.84M2021: -$24.56M2022: -$32.81M2023: -$29.25M2024: -$20.72M2025: -$8.20M-$8.20M1998Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$8.20M+60.4%2024-$20.72M+29.2%2023-$29.25M+10.9%2022-$32.81M-33.6%2021-$24.56M-213.4%2020-$7.84M+59.3%2019-$19.27M-11.9%2018-$17.21M-103.4%2017-$8.46M+28.1%2016-$11.76M-24.1%2015-$9.48M-1.7%2014-$9.32M-99.3%2013-$4.68M-27.7%2012-$3.66M+33.2%2011-$5.48M-88.4%2010-$2.91M-6.3%2009-$2.74M+9.3%2008-$3.02M+9.9%2007-$3.35M+95.6%2006-$76.72M-1992.9%2005-$3.67M-234.2%2004-$1.10M+81.8%2003-$6.01M+49.4%2002-$11.87M+22.9%2001-$15.39M-402.0%2000-$3.07M+71.5%1999-$10.75M-475.9%1998-$1.87M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share